ImmuPharma plc (LON:IMM – Get Free Report)’s stock price rose 86.7% during mid-day trading on Thursday . The company traded as high as GBX 2.49 ($0.03) and last traded at GBX 2.24 ($0.03). Approximately 12,117,709 shares changed hands during mid-day trading, an increase of 314% from the average daily volume of 2,929,006 shares. The stock had previously closed at GBX 1.20 ($0.01).
ImmuPharma Trading Up 4.9 %
The company’s 50 day simple moving average is GBX 1.40 and its 200-day simple moving average is GBX 1.65. The company has a market capitalization of £15.30 million, a price-to-earnings ratio of -367.30 and a beta of 1.53.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Recommended Stories
- Five stocks we like better than ImmuPharma
- Using the MarketBeat Dividend Tax Calculator
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How to Evaluate a Stock Before Buying
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is the S&P 500 and How It is Distinct from Other Indexes
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
